Cabozantinib (Cabometyx™)

  • Trial Availability: USA
  • Tumor Target: Neurofibroma and Vestibular Schwannoma
  • Treatment by: Pill - Oral
  • Inhibitor: VEGF receptor

(Cabometyx™) has not been approved as an NF2 trial on its own, but some locations are using it in combination with Avastin as an enhancer to improve the the percentage of tumor reduction. On its own Cabometyx is on trial for many Cancers as well as NF1 - Plexiform Neurofibromas - NCT02101736.

What is NF2? | About Us | Treatment Options | Sitemap

Disclaimer: Neurofibromatosis Type 2 - Information and Services, www.nf2is.org, is not run by medical experts, affiliated with any healthcare organization or any other company. No assurance can be made to the accuracy or completeness of the information provided here, the accuracy of other sites to which this site links, or of sites that link to this site. - Read More

Copyright © 2008 - 2017